GUGGENHEIM CAPITAL LLC - ONCOGENEX PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
GUGGENHEIM CAPITAL LLC ownership history of ONCOGENEX PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2017$5,000
-28.6%
14,8230.0%0.00%
Q1 2017$7,000
+16.7%
14,823
+24.2%
0.00%
Q4 2016$6,0000.0%11,9350.0%0.00%
Q3 2016$6,000
-50.0%
11,935
-1.6%
0.00%
Q2 2016$12,000
+50.0%
12,1240.0%0.00%
Q1 2016$8,00012,1240.00%
Other shareholders
ONCOGENEX PHARMACEUTICALS IN shareholders Q3 2017
NameSharesValueWeighting ↓
Abingworth LLP 396,104$400,0000.42%
Ancora Advisors LLC 50,865$51,0000.01%
Acrospire Investment Management LLC 5,200$5,0000.00%
EAGLE GLOBAL ADVISORS LLC 145,710$146,0000.00%
A.R.T. Advisors, LLC 57,954$57,0000.00%
Renaissance Technologies 876,100$876,0000.00%
PANAGORA ASSET MANAGEMENT INC 133,846$134,0000.00%
Cutler Group LLC / CA 11,048$11,0000.00%
PRELUDE CAPITAL MANAGEMENT, LLC 4,600$5,0000.00%
Timber Hill LLC 10,663$11,0000.00%
View complete list of ONCOGENEX PHARMACEUTICALS IN shareholders